| Full Name | Max Chen |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 505 N Jackson St, Jackson, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871755058 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD434795 (Pennsylvania) | Primary |
| Entity Name | Center For Family Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780784439 PECOS PAC ID: 4587574421 Enrollment ID: O20040219000916 |
News Archive
Concerns about terrorist attacks, the prospect of a rogue nation using nuclear weapons and the Fukushima power plant accident in Japan are fostering efforts to develop a new family of drugs that everyone hopes will never be used, according to an article in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
U.S. health care workers, especially doctors and nurses, use complementary and alternative medicine (CAM) far more than do workers in other fields, according to a new study. CAM includes diverse therapies outside the realm of conventional medicine.
A blood test to watch breast cancer's ‘molecular clock' could help track the growth of multiple tumors around the body and monitor how they are responding to treatment, new research suggests.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
RNL Bio Co., Ltd, (www.rnl.co.kr) a leading biopharmaceutical company specialized in adult stem cell therapeutics announced today that a 46-year-old female, Kang Sook Park's Multiple Sclerosis improved tremendously after receiving stem cell treatment. Park was suffering from MS (Multiple Sclerosis), an autoimmune disease that affects the central nervous system (brain and spinal cord).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Max Chen, MD 505 N Jackson St, Jackson, MI 49201-1266 Ph: (517) 748-5500 | Max Chen, MD 505 N Jackson St, Jackson, MI 49201 Ph: (517) 748-5500 |
News Archive
Concerns about terrorist attacks, the prospect of a rogue nation using nuclear weapons and the Fukushima power plant accident in Japan are fostering efforts to develop a new family of drugs that everyone hopes will never be used, according to an article in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
U.S. health care workers, especially doctors and nurses, use complementary and alternative medicine (CAM) far more than do workers in other fields, according to a new study. CAM includes diverse therapies outside the realm of conventional medicine.
A blood test to watch breast cancer's ‘molecular clock' could help track the growth of multiple tumors around the body and monitor how they are responding to treatment, new research suggests.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
RNL Bio Co., Ltd, (www.rnl.co.kr) a leading biopharmaceutical company specialized in adult stem cell therapeutics announced today that a 46-year-old female, Kang Sook Park's Multiple Sclerosis improved tremendously after receiving stem cell treatment. Park was suffering from MS (Multiple Sclerosis), an autoimmune disease that affects the central nervous system (brain and spinal cord).
› Verified 8 days ago
Dr. Muna Balkash, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4645 Eagle Dr, Jackson, MI 49201 Phone: 517-783-5508 Fax: 517-783-5508 | |
Hinna Singh, Pediatrics Medicare: Medicare Enrolled Practice Location: 505 N Jackson St, Jackson, MI 49201 Phone: 517-748-5500 | |
Dr. John S Schuster, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 760 W Franklin St, Jackson, MI 49201 Phone: 517-205-2700 Fax: 517-205-2720 | |
Jolene Ellis, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 760 W Franklin St, Jackson, MI 49201 Phone: 517-780-9260 Fax: 517-780-9263 | |
Daniel Robert Fermaglich, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 110 N Elm Ave, Jackson, MI 49202 Phone: 517-788-6760 Fax: 517-788-3029 | |
Dr. Vivien Phung, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 205 N East Ave, Jackson, MI 49201 Phone: 517-205-4800 | |
Dr. Miraflor Reyes, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 505 N Jackson St, Jackson, MI 49201 Phone: 517-748-5500 Fax: 517-780-9286 |